In fact, Szlosarek et al. have reported that the TNF-α neutralizing antibody infliximab reduces TNF-α mRNA level in ovarian cancer cells by blocking the autocrine production loop [13], which is consistent with our findings. This evidence concerns the gene TNF and ovarian carcinoma.